Review article: preventing hepatitis B graft infection in hepatitis B patients after liver transplantation: immunoglobulin vs anti-virals.

Published in: Alimentary pharmacology & therapeutics (2020)

The development of hepatitis B immune globulin and anti-viral treatments led to substantial improvement in graft and patient survival. The prevention of hepatitis B graft reinfection is complex and involves a broad interdisciplinary team.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
case report
palliative care
free survival